Video

Jeff Stark, MD: Final Thoughts on ICD-10 Code for nr-ax-SpA

The ICD-10 code for nr-ax-SpA should be programmed into EHRs in October.

Nonradiographic axial spondyloarthritis (nr-ax-SpA) will have an ICD-10 code come October. And that gives patients with the condition a chance to feel empowered knowing their diagnosis is accurate.

When vendors update their electronic health records (EHRs), typically in October, nr-ax-SpA will be indexed as M46.8, Jeff Stark, MD, head of US medical immunology at UCB, said in a recent interview with HCPLive®.

“We are excited to see that there’s a rapid implementation timeline for this indexing decision made on behalf of the ICD-10 Coordination and Maintenance Committee,” Stark said.

It is anticipated that healthcare providers will see the availability of the code for everyday use in the immediate future. Consistent use of the code is extremely important. Over time, this will facilitate the opportunity to mine databases and generate data about the patients with the disease and the journey they undergo, the epidemiology of the disease, and if they respond to treatment.

Before nr-ax-SpA was indexed as a subcategory, there was a lot of guesswork with diagnosing the disease. Patients did not feel heard and Stark said it was disheartening to be unable to provide the most accurate diagnosis possible.

Now, the new ICD-10 code opens up opportunities to learn more about the disease state and the patients who are affected by it.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.